A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets

International Journal of Antimicrobial Agents

Volumn 24, Issue 6, 2004, Pages 592-598

  Meunier, D ^a   Acar, J F ^b   Martel, J L ^a   Kroemer, S ^c   Valle, M ^c  

^a Healthy Pigs Production and Experimentation Section   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c SYNCHROTRON SOLEIL   (France)

Author keywords

Marbofloxacin; Pets; Survey

Indexed keywords

ANTIBIOTIC AGENT; MARBOFLOXACIN;

BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG SENSITIVITY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OTITIS; PASTEURELLA MULTOCIDA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS INTERMEDIUS; URINARY TRACT INFECTION;

EID: 8844279200     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.09.004     Document Type: Article

References (11)

1. M. Spreng, J. Deleforge, V. Thomas, B. Boisramé, and H. Drugeon Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates J Vet Pharmacol Ther 18 1995 284 289
2. Drugeon H. La pharmacodynamie des antibiotiques. In: Congrs de la Société Franaise de Buiatrie. Paris, France; 1994. p. 3-16.
3. N. Dudley Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones Am J Med 6A 1991 45S 50S
4. T. Pellet, A. Tonnelier, and M. Gicquel Pharmacodynamies de la marbofloxacine sur différentes populations d' Escherichia coli et de Salmonelles de différentes sensibilités 2eme colloque francophone de bactériologie vétérinaire Ploufragan, France 2002 103
5. National Comittee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard M31-A1. Villanova, PA, USA; 1999.
6. National Committee for Clinical Laboratory Standards (NCCLS). Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents; approved standard M37-A1. Villanova, PA, USA; 1999.
7. F. Pirro, M. Edingloh, and N. Schmeer Bactericidal and inhibitory activity of enrofloxacin and other fluoroquinolones in small animal pathogens Third international veterinary symposium on fluoroquinolones proceedings supplement to compendium on continuing education for the practicing veterinarian, vol. 12 1999 21
8. D. Meunier, J.F. Acar, J.L. Martel, S. Kroemer, and M. Vallé Seven years of survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries J Antimicrob Agents 24 2004 70 80
9. T.M. Tejedor, J.L. Martin, M. Navia, J. Freixes, and J. Vila Mechanisms of fluroquinolone resistance in Pseudomonas aeruginosa isolated from canine infections Vet Microbiol 94 2003 295 301
10. F. Pirro In-vitro-Aktivität von Enrofloxacin und anderen Fluorochinolonen bei Krankheitserregern von klein- und Nutztieren Tierärztl Umschau 55 2000 389 397
11. M. Carbone, M.G. Pennisi, M. Masucci, A. De Sarro, M. Giannone, and M.T. Fera Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates Vet Microbiol 81 2001 79 84